A recent study published in Pharmacological Research reported on the impact of one of the compounds in Vitamin E called delta-tocotrienol to almost double the survival rate for ovarian cancer patients. The study compared the survival rates between the FDA approved drug Avastin verses Avastin with delta-tocotrienol included.
The researchers found that Avastin by itself was able to stabilize and control the ovarian cancer over a six-month period in 25% of the patients. When the delta vitamin was added, the survival rate doubled to 50%! This is quite a powerful result for simply adding a vitamin to the mix.
What the study didn’t examine was what the delta vitamin by itself would have done to the cancer survival rate. While this study was only looking at the vitamin’s impact on ovarian cancer, you might want to talk with your doctor about including it as part of your treatment for other types of cancers.
The researchers found that Avastin by itself was able to stabilize and control the ovarian cancer over a six-month period in 25% of the patients. When the delta vitamin was added, the survival rate doubled to 50%! This is quite a powerful result for simply adding a vitamin to the mix.
What the study didn’t examine was what the delta vitamin by itself would have done to the cancer survival rate. While this study was only looking at the vitamin’s impact on ovarian cancer, you might want to talk with your doctor about including it as part of your treatment for other types of cancers.
No comments:
Post a Comment